Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shell shakes up executive committee

(Sharecast News) - Shell's head of integrated gas and upstream is to leave the company, it was confirmed on Tuesday, following a shake-up of the oil major's executive committee. Shell said that Zoe Yujnovich, who has been with the blue chip for more than a decade, will step down at the end of March.

Her role will then be split, with current vice president of liquified natural gas Cederic Cremers taking over as president of integrated gas, and Peter Costello becoming president of upstream. Costello is vice president of conventional oil and gas.

Both will join the executive committee as of 1 April.

Chief executive Wael Sawan said the overhaul was intended to simplify the leadership structure.

He said: "We have made significant progress in the last two years building stability with a track record of strong performance and active management while simplifying our business.

"Now is the right time to begin the next phase of our transformation. Going forward, we will delayer our most senior leadership structure to reflect the three primary eras of business value - integrated gas; upstream; and downstream, renewables and energy solutions - while also elevating trading and supply, a key enabler across the organisation."

He added that Yujnovich's "outstanding impact as a leader leaves a lasting legacy, and positions us strongly for the future.

"I wish Zoe success in all that lies ahead."

Yujnovich will leave the business following a transition period, Shell noted.

Shell has already named Andrew Smith as head of trading and supply and Machteld de Haan as president of downstream. They will also join the executive committee on 1 April.

Sawan, who launched a company-wide review in 2023, wants Shell to refocus on business segments with the highest returns.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.